Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 101. Boucher E A, Burke M M, Johnson P N, Klein K C, Miller J L. Minimum requirements for core competency in pediatric pharmacy practice. Journal of Pediatric Pharmacology and Therapeutics. 2015; 20 : 458-61
102. Heard A N, Miller J L, Couloures K, Johnson P N. Non-intravenous sedatives for procedural sedation for imaging procedures in children. Journal of Pediatric Pharmacology and Therapeutics. 2015; 20 : 418-30
103. Ibach B W, Loeber C, Shukry M, Hagemann T M, Harrison D, Johnson P N. Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusion. Journal of opioid management. 2015; 11 : 295-303
104. Johnson P N. Pain and Sedation. Pediatric Pharmacy Advocacy Group. 2015 : 433-59
105. Oldham M M, Burton M E, Johnson P N, Miller J L. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014; 71 : 2108-9
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 6. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.
7. American Society of Health-System Pharmacists Fellow (FASHP). Date: 2021.
8. American Association for Colleges of Pharmacy. Walmart Scholar Mentor (for Laura Salemi). Date: 2020.
9. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.
10. American College of Clinical Pharmacy Pediatric Pharmacy Practice and Research Network. Outstanding Practitioner Award. Date: 2018.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results